Biosensor for the Detection of Antibodies and Small Molecules
A novel platform technology for point-of-care non-invasive tests.
Tech ID #: 872.5
BACKGROUND
Researchers at the University of Calgary have created a point-of-care (POC) biosensor platform for any small molecule or biological samples. This biosensor relies on cognate enzyme complementation and produces glucose as a final product. The resultant glucose can be easily measured using common or custom-build glucometers. This new method provides a way to detect a wide range of analytes in various biological samples, including blood and colostrum, with a high degree of specificity and sensitivity.
AREAS OF APPLICATION
Verified in clinical samples:
- Small molecule detection – bovine serum calcium test for hypocalcaemia diagnosis1.
- Antibody detection – sera antibody test against bovine leukemia virus (BLV)2,3.
- Immunoglobulin detection:
- Serum IgG concentration test in various animal species4.
- Colostrum IgG concentration test5.
- Genetic targets, after amplicons by PCR or isothermal amplification (LAMP)6.
- Protein aggregation detection3.
COMPETITIVE ADVANTAGES
- High sensitivity and specificity demonstrated on various clinical samples.
- Portable, inexpensive, and simple to use – direct use on biological samples, no purification or processing needed.
- Fast – test results can be available within 10 minutes.
- The inventor has access to large animal resources for clinical trials.
PUBLICATIONS AND RESOURCES